Literature DB >> 25605667

A hybrid feature selection approach for the early diagnosis of Alzheimer's disease.

Esteve Gallego-Jutglà1, Jordi Solé-Casals, François-Benoît Vialatte, Mohamed Elgendi, Andrzej Cichocki, Justin Dauwels.   

Abstract

OBJECTIVE: Recently, significant advances have been made in the early diagnosis of Alzheimer's disease (AD) from electroencephalography (EEG). However, choosing suitable measures is a challenging task. Among other measures, frequency relative power (RP) and loss of complexity have been used with promising results. In the present study we investigate the early diagnosis of AD using synchrony measures and frequency RP on EEG signals, examining the changes found in different frequency ranges. APPROACH: We first explore the use of a single feature for computing the classification rate (CR), looking for the best frequency range. Then, we present a multiple feature classification system that outperforms all previous results using a feature selection strategy. These two approaches are tested in two different databases, one containing mild cognitive impairment (MCI) and healthy subjects (patients age: 71.9 ± 10.2, healthy subjects age: 71.7 ± 8.3), and the other containing Mild AD and healthy subjects (patients age: 77.6 ± 10.0; healthy subjects age: 69.4 ± 11.5). MAIN
RESULTS: Using a single feature to compute CRs we achieve a performance of 78.33% for the MCI data set and of 97.56% for Mild AD. Results are clearly improved using the multiple feature classification, where a CR of 95% is found for the MCI data set using 11 features, and 100% for the Mild AD data set using four features. SIGNIFICANCE: The new features selection method described in this work may be a reliable tool that could help to design a realistic system that does not require prior knowledge of a patient's status. With that aim, we explore the standardization of features for MCI and Mild AD data sets with promising results.

Entities:  

Mesh:

Year:  2015        PMID: 25605667     DOI: 10.1088/1741-2560/12/1/016018

Source DB:  PubMed          Journal:  J Neural Eng        ISSN: 1741-2552            Impact factor:   5.379


  6 in total

1.  Combining SPECT and Quantitative EEG Analysis for the Automated Differential Diagnosis of Disorders with Amnestic Symptoms.

Authors:  Yvonne Höller; Arne C Bathke; Andreas Uhl; Nicolas Strobl; Adelheid Lang; Jürgen Bergmann; Raffaele Nardone; Fabio Rossini; Harald Zauner; Margarita Kirschner; Amirhossein Jahanbekam; Eugen Trinka; Wolfgang Staffen
Journal:  Front Aging Neurosci       Date:  2017-09-07       Impact factor: 5.750

2.  Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment.

Authors:  Raymundo Cassani; Mar Estarellas; Rodrigo San-Martin; Francisco J Fraga; Tiago H Falk
Journal:  Dis Markers       Date:  2018-10-04       Impact factor: 3.434

3.  Distinct Slow-Wave Activity Patterns in Resting-State Electroencephalography and Their Relation to Language Functioning in Low-Grade Glioma and Meningioma Patients.

Authors:  Nienke Wolthuis; Ingeborg Bosma; Roelien Bastiaanse; Perumpillichira J Cherian; Marion Smits; Wencke Veenstra; Michiel Wagemakers; Arnaud Vincent; Djaina Satoer
Journal:  Front Hum Neurosci       Date:  2022-03-24       Impact factor: 3.169

4.  An Automated Approach for the Detection of Alzheimer's Disease From Resting State Electroencephalography.

Authors:  Eduardo Perez-Valero; Christian Morillas; Miguel A Lopez-Gordo; Ismael Carrera-Muñoz; Samuel López-Alcalde; Rosa M Vílchez-Carrillo
Journal:  Front Neuroinform       Date:  2022-07-11       Impact factor: 3.739

5.  Complex network analysis of resting state EEG in amnestic mild cognitive impairment patients with type 2 diabetes.

Authors:  Ke Zeng; Yinghua Wang; Gaoxiang Ouyang; Zhijie Bian; Lei Wang; Xiaoli Li
Journal:  Front Comput Neurosci       Date:  2015-10-29       Impact factor: 2.380

6.  Changes in electroencephalography and sleep architecture as potential electrical biomarkers for Alzheimer's disease.

Authors:  Hang Yu; Man-Li Wang; Xiao-Lan Xu; Rong Zhang; Wei-Dong Le
Journal:  Chin Med J (Engl)       Date:  2021-02-23       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.